PharmaTimes July 31, 2024
The latest collaboration marks Apollo’s sixth agreement with a research institution
Apollo Therapeutics and the University of Oxford have entered into a drug discovery and development collaboration to translate breakthroughs by biomedical researchers at Oxford.
As part of the deal, Apollo will identify and assess novel, validated therapeutic targets from Oxford’s researchers to potentially become important new medicines, while Oxford researchers will gain access to therapeutic development expertise and programme funding from Apollo.
Apollo’s drug discovery experts will help identify the medicines with the most potential to transform the standard of care globally by supporting the development of new medicines across areas including oncology, immunological and inflammatory disorders.
Furthermore, programme funding from Apollo will help to provide more access to...
Today's Sponsors
Today's Sponsor